These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 12881723)
1. Identification of Stk6/STK15 as a candidate low-penetrance tumor-susceptibility gene in mouse and human. Ewart-Toland A; Briassouli P; de Koning JP; Mao JH; Yuan J; Chan F; MacCarthy-Morrogh L; Ponder BA; Nagase H; Burn J; Ball S; Almeida M; Linardopoulos S; Balmain A Nat Genet; 2003 Aug; 34(4):403-12. PubMed ID: 12881723 [TBL] [Abstract][Full Text] [Related]
2. Simultaneous Aurora-A/STK15 overexpression and centrosome amplification induce chromosomal instability in tumour cells with a MIN phenotype. Lentini L; Amato A; Schillaci T; Di Leonardo A BMC Cancer; 2007 Nov; 7():212. PubMed ID: 17999753 [TBL] [Abstract][Full Text] [Related]
3. Aurora-A/STK15 T+91A is a general low penetrance cancer susceptibility gene: a meta-analysis of multiple cancer types. Ewart-Toland A; Dai Q; Gao YT; Nagase H; Dunlop MG; Farrington SM; Barnetson RA; Anton-Culver H; Peel D; Ziogas A; Lin D; Miao X; Sun T; Ostrander EA; Stanford JL; Langlois M; Chan JM; Yuan J; Harris CC; Bowman ED; Clayman GL; Lippman SM; Lee JJ; Zheng W; Balmain A Carcinogenesis; 2005 Aug; 26(8):1368-73. PubMed ID: 15802297 [TBL] [Abstract][Full Text] [Related]
4. Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Zhou H; Kuang J; Zhong L; Kuo WL; Gray JW; Sahin A; Brinkley BR; Sen S Nat Genet; 1998 Oct; 20(2):189-93. PubMed ID: 9771714 [TBL] [Abstract][Full Text] [Related]
5. Amplification/overexpression of a mitotic kinase gene in human bladder cancer. Sen S; Zhou H; Zhang RD; Yoon DS; Vakar-Lopez F; Ito S; Jiang F; Johnston D; Grossman HB; Ruifrok AC; Katz RL; Brinkley W; Czerniak B J Natl Cancer Inst; 2002 Sep; 94(17):1320-9. PubMed ID: 12208897 [TBL] [Abstract][Full Text] [Related]
6. STK15 polymorphisms and association with risk of invasive ovarian cancer. Dicioccio RA; Song H; Waterfall C; Kimura MT; Nagase H; McGuire V; Hogdall E; Shah MN; Luben RN; Easton DF; Jacobs IJ; Ponder BA; Whittemore AS; Gayther SA; Pharoah PD; Kruger-Kjaer S Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1589-94. PubMed ID: 15466974 [TBL] [Abstract][Full Text] [Related]
7. Frequent overexpression of STK15/Aurora-A/BTAK and chromosomal instability in tumorigenic cell cultures derived from human ovarian cancer. Hu W; Kavanagh JJ; Deaver M; Johnston DA; Freedman RS; Verschraegen CF; Sen S Oncol Res; 2005; 15(1):49-57. PubMed ID: 15839305 [TBL] [Abstract][Full Text] [Related]
8. Detailed chromosomal characterization of the breast cancer cell line MCF7 with special focus on the expression of the serine-threonine kinase 15. Klein A; Jung V; Zang KD; Henn W; Montenarh M; Kartarius S; Steudel WI; Urbschat S Oncol Rep; 2005 Jul; 14(1):23-31. PubMed ID: 15944763 [TBL] [Abstract][Full Text] [Related]
9. Interaction and feedback regulation between STK15/BTAK/Aurora-A kinase and protein phosphatase 1 through mitotic cell division cycle. Katayama H; Zhou H; Li Q; Tatsuka M; Sen S J Biol Chem; 2001 Dec; 276(49):46219-24. PubMed ID: 11551964 [TBL] [Abstract][Full Text] [Related]
10. Breast cancer risk associated with genotypic polymorphism of the mitosis-regulating gene Aurora-A/STK15/BTAK. Lo YL; Yu JC; Chen ST; Yang HC; Fann CS; Mau YC; Shen CY Int J Cancer; 2005 Jun; 115(2):276-83. PubMed ID: 15688402 [TBL] [Abstract][Full Text] [Related]
11. Aurora2/BTAK/STK15 is involved in cell cycle checkpoint and cell survival of aggressive non-Hodgkin's lymphoma. Hamada M; Yakushijin Y; Ohtsuka M; Kakimoto M; Yasukawa M; Fujita S Br J Haematol; 2003 May; 121(3):439-47. PubMed ID: 12716366 [TBL] [Abstract][Full Text] [Related]
12. Aurora-A/STK15/BTAK enhances chromosomal instability in bladder cancer cells. Fraizer GC; Diaz MF; Lee IL; Grossman HB; Sen S Int J Oncol; 2004 Dec; 25(6):1631-9. PubMed ID: 15547700 [TBL] [Abstract][Full Text] [Related]
13. Functional STK15 Phe31Ile polymorphism is associated with the occurrence and advanced disease status of esophageal squamous cell carcinoma. Miao X; Sun T; Wang Y; Zhang X; Tan W; Lin D Cancer Res; 2004 Apr; 64(8):2680-3. PubMed ID: 15087379 [TBL] [Abstract][Full Text] [Related]
14. The putative serine/threonine kinase gene STK15 on chromosome 20q13.2 is amplified in human gliomas. Reichardt W; Jung V; Brunner C; Klein A; Wemmert S; Romeike BF; Zang KD; Urbschat S Oncol Rep; 2003; 10(5):1275-9. PubMed ID: 12883693 [TBL] [Abstract][Full Text] [Related]
15. The N-terminal domain of the Aurora-A Phe-31 variant encodes an E3 ubiquitin ligase and mediates ubiquitination of IkappaBalpha. Briassouli P; Chan F; Linardopoulos S Hum Mol Genet; 2006 Nov; 15(22):3343-50. PubMed ID: 17060341 [TBL] [Abstract][Full Text] [Related]
16. Allele-specific Hras mutations and genetic alterations at tumor susceptibility loci in skin carcinomas from interspecific hybrid mice. Nagase H; Mao JH; Balmain A Cancer Res; 2003 Aug; 63(16):4849-53. PubMed ID: 12941805 [TBL] [Abstract][Full Text] [Related]
17. Aneuploidy of human testicular germ cell tumors is associated with amplification of centrosomes. Mayer F; Stoop H; Sen S; Bokemeyer C; Oosterhuis JW; Looijenga LH Oncogene; 2003 Jun; 22(25):3859-66. PubMed ID: 12813459 [TBL] [Abstract][Full Text] [Related]
18. Functional Phe31Ile polymorphism in Aurora A and risk of breast carcinoma. Sun T; Miao X; Wang J; Tan W; Zhou Y; Yu C; Lin D Carcinogenesis; 2004 Nov; 25(11):2225-30. PubMed ID: 15271856 [TBL] [Abstract][Full Text] [Related]
19. Two functional coding single nucleotide polymorphisms in STK15 (Aurora-A) coordinately increase esophageal cancer risk. Kimura MT; Mori T; Conroy J; Nowak NJ; Satomi S; Tamai K; Nagase H Cancer Res; 2005 May; 65(9):3548-54. PubMed ID: 15867347 [TBL] [Abstract][Full Text] [Related]
20. Genetic variants of Tgfb1 act as context-dependent modifiers of mouse skin tumor susceptibility. Mao JH; Saunier EF; de Koning JP; McKinnon MM; Higgins MN; Nicklas K; Yang HT; Balmain A; Akhurst RJ Proc Natl Acad Sci U S A; 2006 May; 103(21):8125-30. PubMed ID: 16702541 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]